RaySearch Laboratories AB (publ) (RAY_B) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to the presentation of Research Interim Report for the first quarter of 2025. My name is Henrik Preyfors and I will be the moderator today. Joining us in today's call is Johan Lööf, Research Founder and CEO, and Nina Grönberg, our CFO. Johan and Nina will give you a brief summary of the quarter, including the financials, and after that, we open up for questions. I also want to remind you that this session is being recorded, and you will be able to find it on our website in the upcoming days. With that, I hand it over to you, Johan. Please go ahead. Thank you, Henrik. I would also like to welcome all of you to today's webcast. I'm happy to announce that our sales for the first quarter were our highest ever, 332 million Swedish crowns. Compared with the same period of 2024, the increase was 29%. Operating profit was 75 million, corresponding to an operating margin of 23%. The improved margin was mainly driven by increased license revenue, which amounted to 165 million, Because of the political turbulence in the US, operating profit was affected more than usual by exchange rate fluctuations. Excluding those, operating profit would have been 95 million Swedish crowns, which corresponds to an operating margin of 29%. Order intake was 410 million, representing a 72% increase. To summarize, we're maintaining a solid momentum and outlook for continued growth remains very positive. In addition, Ray Search has a strong financial position with cash and cash equivalents of 503 billion Swedish crowns, stable cash flow and no loans. In early March, Heiyu Hospital in Foshan City in China, placed an order for Ray Station worth 77 million Swedish crowns. Of this, 26 million was recognized in the first quarter. This is the third largest order in research history and ...